| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chiroptera | 60 | 2021 | 3530 | 5.69 | Why? |
| Disease Reservoirs | 20 | 2021 | 1672 | 2.91 | Why? |
| Henipavirus Infections | 8 | 2020 | 122 | 2.05 | Why? |
| Zoonoses | 14 | 2020 | 3034 | 1.40 | Why? |
| Hendra Virus | 6 | 2019 | 31 | 1.40 | Why? |
| Nipah Virus | 6 | 2020 | 121 | 1.37 | Why? |
| Henipavirus | 6 | 2018 | 24 | 1.34 | Why? |
| SARS Virus | 27 | 2021 | 13021 | 1.25 | Why? |
| Virus Diseases | 9 | 2020 | 3779 | 1.11 | Why? |
| Paramyxovirinae | 2 | 2019 | 49 | 0.90 | Why? |
| Communicable Diseases, Emerging | 5 | 2020 | 2523 | 0.87 | Why? |
| Severe Acute Respiratory Syndrome | 19 | 2021 | 12361 | 0.85 | Why? |
| Animals | 81 | 2021 | 78931 | 0.79 | Why? |
| Disease Resistance | 1 | 2021 | 236 | 0.75 | Why? |
| Early Growth Response Protein 1 | 1 | 2017 | 12 | 0.73 | Why? |
| Paramyxoviridae | 1 | 2018 | 67 | 0.71 | Why? |
| Viruses | 7 | 2020 | 2238 | 0.71 | Why? |
| Genomics | 3 | 2018 | 3118 | 0.68 | Why? |
| Animals, Wild | 2 | 2020 | 1028 | 0.68 | Why? |
| Phylogeny | 23 | 2021 | 13341 | 0.67 | Why? |
| Extracellular Matrix Proteins | 1 | 2017 | 95 | 0.67 | Why? |
| N-Acetylneuraminic Acid | 1 | 2019 | 198 | 0.66 | Why? |
| Nuclear Proteins | 3 | 2018 | 321 | 0.65 | Why? |
| Gene Knockout Techniques | 1 | 2017 | 347 | 0.63 | Why? |
| Genome | 1 | 2018 | 341 | 0.61 | Why? |
| Evolution, Molecular | 9 | 2021 | 3691 | 0.60 | Why? |
| Viverridae | 8 | 2013 | 225 | 0.60 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2017 | 610 | 0.57 | Why? |
| Dengue Virus | 2 | 2019 | 910 | 0.57 | Why? |
| Camelids, New World | 1 | 2016 | 276 | 0.56 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.56 | Why? |
| Receptors, Virus | 8 | 2021 | 5659 | 0.54 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.52 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.52 | Why? |
| Urine | 2 | 2016 | 469 | 0.51 | Why? |
| Antibodies, Viral | 24 | 2021 | 51949 | 0.50 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.50 | Why? |
| Transcriptome | 4 | 2020 | 3466 | 0.49 | Why? |
| Neutralization Tests | 11 | 2021 | 6698 | 0.47 | Why? |
| Disease Vectors | 3 | 2015 | 208 | 0.47 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.47 | Why? |
| Mononegavirales | 3 | 2019 | 9 | 0.46 | Why? |
| Zika Virus | 3 | 2019 | 1924 | 0.45 | Why? |
| Viral Envelope Proteins | 10 | 2018 | 3539 | 0.45 | Why? |
| Host-Pathogen Interactions | 9 | 2020 | 11041 | 0.44 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.43 | Why? |
| Serologic Tests | 5 | 2021 | 4359 | 0.43 | Why? |
| Cell Line, Transformed | 1 | 2009 | 87 | 0.41 | Why? |
| Cell Line | 16 | 2020 | 12040 | 0.41 | Why? |
| Genome, Viral | 17 | 2021 | 13157 | 0.40 | Why? |
| Dengue | 2 | 2019 | 1565 | 0.39 | Why? |
| Molecular Sequence Data | 11 | 2015 | 3198 | 0.38 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.38 | Why? |
| Peptidyl-Dipeptidase A | 7 | 2021 | 9659 | 0.37 | Why? |
| Virus Internalization | 9 | 2019 | 7921 | 0.37 | Why? |
| Gene Expression | 3 | 2018 | 3332 | 0.36 | Why? |
| Membrane Glycoproteins | 6 | 2010 | 2273 | 0.36 | Why? |
| Immunodominant Epitopes | 3 | 2020 | 813 | 0.35 | Why? |
| Viral Proteins | 7 | 2020 | 7370 | 0.34 | Why? |
| Filoviridae | 2 | 2019 | 70 | 0.34 | Why? |
| Singapore | 11 | 2021 | 3641 | 0.33 | Why? |
| Horses | 3 | 2017 | 474 | 0.33 | Why? |
| Virus Attachment | 2 | 2015 | 1259 | 0.33 | Why? |
| Rabies Vaccines | 2 | 2017 | 106 | 0.32 | Why? |
| Coronavirus | 11 | 2020 | 18339 | 0.32 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2013 | 1061 | 0.31 | Why? |
| Amino Acid Sequence | 9 | 2021 | 6049 | 0.31 | Why? |
| Pentanoic Acids | 1 | 2005 | 9 | 0.30 | Why? |
| Nucleocapsid Proteins | 5 | 2021 | 3120 | 0.30 | Why? |
| RNA Viruses | 3 | 2019 | 824 | 0.30 | Why? |
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 3633 | 0.30 | Why? |
| Molecular Sequence Annotation | 3 | 2018 | 478 | 0.29 | Why? |
| Tetrahydronaphthalenes | 1 | 2005 | 32 | 0.29 | Why? |
| Cell Culture Techniques | 1 | 2009 | 704 | 0.29 | Why? |
| Immunity | 1 | 2016 | 2651 | 0.29 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.28 | Why? |
| Antigen Presentation | 2 | 2019 | 524 | 0.28 | Why? |
| Australia | 6 | 2019 | 6306 | 0.28 | Why? |
| Open Reading Frames | 4 | 2020 | 1898 | 0.27 | Why? |
| Malaysia | 2 | 2019 | 1116 | 0.27 | Why? |
| RNA Virus Infections | 2 | 2017 | 231 | 0.27 | Why? |
| Coronavirus Infections | 22 | 2020 | 253789 | 0.26 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.26 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 4 | 2019 | 8843 | 0.26 | Why? |
| Receptors, Cell Surface | 3 | 2021 | 586 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.25 | Why? |
| Genetic Variation | 8 | 2020 | 3919 | 0.25 | Why? |
| Geography | 3 | 2021 | 1801 | 0.24 | Why? |
| Protein Domains | 3 | 2021 | 6563 | 0.24 | Why? |
| Immune System | 1 | 2012 | 1479 | 0.24 | Why? |
| Betacoronavirus | 17 | 2020 | 204454 | 0.24 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.24 | Why? |
| Swine | 3 | 2018 | 3352 | 0.23 | Why? |
| Immunity, Innate | 6 | 2020 | 6570 | 0.23 | Why? |
| Animals, Laboratory | 1 | 2021 | 40 | 0.23 | Why? |
| Humans | 82 | 2021 | 930598 | 0.22 | Why? |
| Gammaretrovirus | 1 | 2020 | 6 | 0.22 | Why? |
| Lentiviruses, Primate | 1 | 2020 | 11 | 0.22 | Why? |
| Spumavirus | 1 | 2020 | 14 | 0.22 | Why? |
| Marburgvirus | 2 | 2019 | 71 | 0.22 | Why? |
| Bangladesh | 2 | 2018 | 1620 | 0.21 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 7868 | 0.21 | Why? |
| Ebolavirus | 3 | 2019 | 834 | 0.21 | Why? |
| Antibodies, Neutralizing | 11 | 2021 | 25288 | 0.21 | Why? |
| Immunoprecipitation | 1 | 2020 | 300 | 0.20 | Why? |
| Gene Deletion | 2 | 2020 | 430 | 0.20 | Why? |
| Camelus | 2 | 2019 | 1425 | 0.20 | Why? |
| Australasia | 1 | 2019 | 89 | 0.20 | Why? |
| Pneumonia, Viral | 15 | 2021 | 243684 | 0.20 | Why? |
| Orthoreovirus | 1 | 2019 | 5 | 0.20 | Why? |
| Asia, Southeastern | 1 | 2021 | 390 | 0.20 | Why? |
| Microscopy, Confocal | 2 | 2018 | 343 | 0.19 | Why? |
| Rabies | 2 | 2017 | 113 | 0.19 | Why? |
| DNA Damage | 2 | 2018 | 285 | 0.19 | Why? |
| Phoeniceae | 1 | 2018 | 4 | 0.19 | Why? |
| Cytosine Deaminase | 1 | 2018 | 14 | 0.19 | Why? |
| Reoviridae Infections | 1 | 2019 | 31 | 0.19 | Why? |
| Ephrin-B2 | 1 | 2018 | 3 | 0.19 | Why? |
| Spike Glycoprotein, Coronavirus | 15 | 2021 | 37182 | 0.19 | Why? |
| Molecular Diagnostic Techniques | 1 | 2015 | 4239 | 0.19 | Why? |
| Peptides | 2 | 2016 | 2513 | 0.19 | Why? |
| Complement C1q | 1 | 2018 | 31 | 0.18 | Why? |
| Papua New Guinea | 1 | 2018 | 63 | 0.18 | Why? |
| Alternative Splicing | 1 | 2018 | 82 | 0.18 | Why? |
| Cell Nucleolus | 1 | 2018 | 59 | 0.18 | Why? |
| bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.18 | Why? |
| Gene Pool | 1 | 2017 | 15 | 0.18 | Why? |
| Receptors, Antigen, B-Cell | 2 | 2019 | 424 | 0.18 | Why? |
| Interferons | 4 | 2018 | 2885 | 0.18 | Why? |
| Abattoirs | 1 | 2018 | 94 | 0.18 | Why? |
| Species Specificity | 4 | 2013 | 1356 | 0.18 | Why? |
| Parotid Gland | 1 | 2017 | 53 | 0.18 | Why? |
| Bone Marrow Cells | 1 | 2019 | 186 | 0.17 | Why? |
| Disease Outbreaks | 11 | 2020 | 27595 | 0.17 | Why? |
| Sequence Analysis, DNA | 6 | 2015 | 2830 | 0.17 | Why? |
| Filoviridae Infections | 1 | 2017 | 13 | 0.17 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 66 | 0.17 | Why? |
| Host Specificity | 2 | 2020 | 926 | 0.17 | Why? |
| Biodiversity | 3 | 2020 | 546 | 0.17 | Why? |
| Toll-Like Receptor 3 | 2 | 2017 | 391 | 0.17 | Why? |
| Adjuvants, Immunologic | 2 | 2017 | 1709 | 0.17 | Why? |
| Antigens, Differentiation | 1 | 2019 | 172 | 0.17 | Why? |
| Information Services | 1 | 2018 | 70 | 0.17 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.17 | Why? |
| Macaca fascicularis | 2 | 2019 | 1009 | 0.17 | Why? |
| Monkey Diseases | 1 | 2019 | 190 | 0.16 | Why? |
| Interferon Regulatory Factors | 1 | 2017 | 141 | 0.16 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.16 | Why? |
| Active Transport, Cell Nucleus | 1 | 2017 | 203 | 0.16 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.16 | Why? |
| Circulating MicroRNA | 1 | 2017 | 123 | 0.16 | Why? |
| Genes, MHC Class I | 1 | 2016 | 81 | 0.16 | Why? |
| Horse Diseases | 1 | 2017 | 101 | 0.16 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.16 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.15 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.15 | Why? |
| Animal Diseases | 1 | 2018 | 182 | 0.15 | Why? |
| Paramyxoviridae Infections | 1 | 2019 | 364 | 0.15 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.15 | Why? |
| Cross Reactions | 4 | 2020 | 4374 | 0.15 | Why? |
| Phosphoproteins | 3 | 2020 | 4346 | 0.15 | Why? |
| Kinetics | 2 | 2020 | 3238 | 0.15 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.15 | Why? |
| Mice | 10 | 2020 | 21357 | 0.14 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.14 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 291 | 0.14 | Why? |
| Mammals | 2 | 2017 | 315 | 0.14 | Why? |
| Phagocytosis | 1 | 2016 | 409 | 0.14 | Why? |
| Histocompatibility Antigens Class I | 1 | 2019 | 624 | 0.14 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.14 | Why? |
| Histocompatibility Antigens Class II | 1 | 2017 | 383 | 0.14 | Why? |
| HEK293 Cells | 4 | 2020 | 8394 | 0.14 | Why? |
| Cathepsins | 1 | 2015 | 204 | 0.14 | Why? |
| Colectomy | 1 | 2017 | 327 | 0.13 | Why? |
| Conserved Sequence | 2 | 2017 | 751 | 0.13 | Why? |
| Antigens | 1 | 2016 | 267 | 0.13 | Why? |
| Microspheres | 1 | 2015 | 261 | 0.13 | Why? |
| RNA | 1 | 2021 | 1278 | 0.13 | Why? |
| Disease Models, Animal | 5 | 2021 | 10998 | 0.13 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.13 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.13 | Why? |
| Indonesia | 1 | 2018 | 1022 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Asymptomatic Diseases | 3 | 2021 | 3444 | 0.13 | Why? |
| Protein Interaction Mapping | 2 | 2013 | 487 | 0.13 | Why? |
| Alphacoronavirus | 1 | 2018 | 392 | 0.13 | Why? |
| Endoribonucleases | 1 | 2017 | 407 | 0.13 | Why? |
| Histocompatibility Antigens | 1 | 2012 | 38 | 0.12 | Why? |
| Africa | 3 | 2018 | 2986 | 0.12 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.12 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.12 | Why? |
| Computational Biology | 2 | 2018 | 4514 | 0.12 | Why? |
| Colon | 1 | 2017 | 669 | 0.12 | Why? |
| Cluster Analysis | 3 | 2020 | 3001 | 0.12 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.12 | Why? |
| Selection, Genetic | 2 | 2013 | 691 | 0.12 | Why? |
| Virus Replication | 7 | 2020 | 14331 | 0.12 | Why? |
| Immunophenotyping | 1 | 2016 | 1290 | 0.11 | Why? |
| Livestock | 1 | 2012 | 184 | 0.11 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.11 | Why? |
| Recombination, Genetic | 4 | 2020 | 1265 | 0.11 | Why? |
| Coronaviridae Infections | 1 | 2015 | 442 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2012 | 368 | 0.11 | Why? |
| Viral Fusion Proteins | 1 | 2015 | 399 | 0.11 | Why? |
| Metagenome | 1 | 2013 | 268 | 0.11 | Why? |
| Sequence Alignment | 3 | 2012 | 2109 | 0.11 | Why? |
| Simian virus 40 | 1 | 2009 | 9 | 0.11 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.11 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.11 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.11 | Why? |
| Cell Shape | 1 | 2009 | 57 | 0.10 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.10 | Why? |
| Viral Matrix Proteins | 2 | 2017 | 1243 | 0.10 | Why? |
| RNA, Viral | 8 | 2021 | 32276 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Viral Vaccines | 4 | 2020 | 7560 | 0.10 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.10 | Why? |
| Coronaviridae | 1 | 2015 | 923 | 0.10 | Why? |
| Poly I-C | 1 | 2009 | 176 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.10 | Why? |
| Virus Shedding | 4 | 2020 | 5834 | 0.10 | Why? |
| Cloning, Molecular | 2 | 2009 | 1036 | 0.10 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2011 | 379 | 0.09 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.09 | Why? |
| Virulence Factors | 1 | 2011 | 338 | 0.09 | Why? |
| Adenoviridae Infections | 1 | 2010 | 150 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2019 | 2093 | 0.09 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.09 | Why? |
| CRISPR-Cas Systems | 1 | 2017 | 1397 | 0.09 | Why? |
| Receptors, Immunologic | 1 | 2012 | 555 | 0.09 | Why? |
| Rats | 3 | 2017 | 2764 | 0.09 | Why? |
| Dendritic Cells | 1 | 2016 | 1330 | 0.09 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.09 | Why? |
| Furin | 1 | 2015 | 1054 | 0.08 | Why? |
| Adenoviridae | 2 | 2013 | 1151 | 0.08 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Peptide Hydrolases | 1 | 2015 | 1269 | 0.08 | Why? |
| Rabies virus | 2 | 2017 | 92 | 0.08 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.08 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.08 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Vietnam | 2 | 2021 | 1665 | 0.08 | Why? |
| Virulence | 3 | 2020 | 2172 | 0.07 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.07 | Why? |
| Kenya | 2 | 2019 | 887 | 0.07 | Why? |
| Mycotoxins | 1 | 2005 | 19 | 0.07 | Why? |
| Nuclear Localization Signals | 2 | 2017 | 85 | 0.07 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.07 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.07 | Why? |
| Female | 18 | 2021 | 380317 | 0.07 | Why? |
| China | 12 | 2020 | 50654 | 0.07 | Why? |
| HeLa Cells | 3 | 2018 | 1303 | 0.07 | Why? |
| Vero Cells | 5 | 2017 | 14117 | 0.07 | Why? |
| Seroepidemiologic Studies | 4 | 2020 | 10017 | 0.07 | Why? |
| Recombinant Fusion Proteins | 1 | 2010 | 919 | 0.07 | Why? |
| Protein Binding | 4 | 2018 | 11430 | 0.07 | Why? |
| Macrophages | 1 | 2016 | 2784 | 0.07 | Why? |
| Base Sequence | 2 | 2020 | 3581 | 0.07 | Why? |
| Polymerase Chain Reaction | 3 | 2020 | 6740 | 0.07 | Why? |
| Rabbits | 1 | 2007 | 1171 | 0.07 | Why? |
| Antibodies, Monoclonal | 3 | 2010 | 8041 | 0.07 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.07 | Why? |
| Ferrets | 2 | 2020 | 1201 | 0.07 | Why? |
| Adaptation, Physiological | 1 | 2007 | 359 | 0.06 | Why? |
| Glycoproteins | 2 | 2019 | 615 | 0.06 | Why? |
| Models, Biological | 3 | 2020 | 4907 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Green Fluorescent Proteins | 2 | 2018 | 450 | 0.06 | Why? |
| Post-Exposure Prophylaxis | 2 | 2017 | 472 | 0.06 | Why? |
| Sequence Homology, Amino Acid | 3 | 2011 | 945 | 0.06 | Why? |
| Cell Fusion | 2 | 2018 | 400 | 0.06 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.06 | Why? |
| Sequence Analysis, RNA | 3 | 2018 | 2290 | 0.06 | Why? |
| Aotidae | 1 | 2020 | 14 | 0.06 | Why? |
| Male | 17 | 2021 | 367725 | 0.06 | Why? |
| Healthy Volunteers | 2 | 2017 | 1444 | 0.06 | Why? |
| Adult | 15 | 2021 | 244371 | 0.05 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Spatio-Temporal Analysis | 2 | 2018 | 1182 | 0.05 | Why? |
| Tripartite Motif Proteins | 1 | 2020 | 44 | 0.05 | Why? |
| 3T3 Cells | 1 | 2020 | 152 | 0.05 | Why? |
| Bayes Theorem | 2 | 2020 | 3237 | 0.05 | Why? |
| Acute-Phase Reaction | 1 | 2021 | 116 | 0.05 | Why? |
| India | 1 | 2018 | 11875 | 0.05 | Why? |
| Sri Lanka | 1 | 2021 | 241 | 0.05 | Why? |
| Viral Tropism | 2 | 2019 | 1329 | 0.05 | Why? |
| DNA Primers | 1 | 2005 | 1170 | 0.05 | Why? |
| Cyclophilin A | 1 | 2020 | 90 | 0.05 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.05 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.05 | Why? |
| Cricetinae | 2 | 2019 | 3344 | 0.05 | Why? |
| RNA, Ribosomal | 1 | 2018 | 39 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.05 | Why? |
| Cytosol | 1 | 2018 | 77 | 0.05 | Why? |
| Cat Diseases | 1 | 2005 | 539 | 0.05 | Why? |
| Salivary Ducts | 1 | 2017 | 19 | 0.05 | Why? |
| Intestines | 1 | 2004 | 817 | 0.04 | Why? |
| Jejunum | 1 | 2018 | 82 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Structure-Activity Relationship | 1 | 2005 | 2219 | 0.04 | Why? |
| Toll-Like Receptor 9 | 1 | 2018 | 72 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2019 | 273 | 0.04 | Why? |
| Nervous System | 1 | 2020 | 303 | 0.04 | Why? |
| Ligation | 1 | 2017 | 84 | 0.04 | Why? |
| Nucleic Acid Conformation | 1 | 2021 | 621 | 0.04 | Why? |
| Cats | 2 | 2020 | 1890 | 0.04 | Why? |
| Sendai virus | 1 | 2018 | 111 | 0.04 | Why? |
| Longitudinal Studies | 3 | 2021 | 9893 | 0.04 | Why? |
| Virosomes | 1 | 2017 | 25 | 0.04 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.04 | Why? |
| Atrophy | 1 | 2017 | 192 | 0.04 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.04 | Why? |
| Recombinant Proteins | 1 | 2007 | 3786 | 0.04 | Why? |
| RNA Interference | 1 | 2020 | 534 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Nucleoproteins | 1 | 2018 | 223 | 0.04 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.04 | Why? |
| Drug Evaluation, Preclinical | 1 | 2008 | 3347 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2017 | 335 | 0.04 | Why? |
| DNA Methylation | 1 | 2021 | 688 | 0.04 | Why? |
| Thailand | 1 | 2021 | 1155 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.04 | Why? |
| Phylogeography | 1 | 2020 | 824 | 0.04 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.04 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2018 | 635 | 0.04 | Why? |
| RNA, Small Interfering | 1 | 2020 | 817 | 0.04 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.04 | Why? |
| Protein Transport | 1 | 2017 | 487 | 0.04 | Why? |
| Ecology | 1 | 2016 | 140 | 0.04 | Why? |
| Carrier State | 1 | 2007 | 2100 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.04 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2021 | 698 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.03 | Why? |
| Virology | 1 | 2019 | 489 | 0.03 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Queensland | 1 | 2015 | 188 | 0.03 | Why? |
| Sequence Homology | 1 | 2015 | 448 | 0.03 | Why? |
| Reverse Genetics | 1 | 2018 | 439 | 0.03 | Why? |
| Protein Structure, Tertiary | 2 | 2010 | 1565 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.03 | Why? |
| Peptide Fragments | 1 | 2005 | 2075 | 0.03 | Why? |
| Antibody Formation | 1 | 2007 | 4038 | 0.03 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.03 | Why? |
| Viral Nonstructural Proteins | 2 | 2008 | 4810 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Biomarkers | 1 | 2016 | 23361 | 0.03 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.03 | Why? |
| Neuroimaging | 1 | 2020 | 1106 | 0.03 | Why? |
| Nose | 1 | 2018 | 1093 | 0.03 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.03 | Why? |
| Disease Susceptibility | 1 | 2005 | 4002 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Feces | 2 | 2016 | 4235 | 0.03 | Why? |
| Dogs | 1 | 2019 | 2529 | 0.03 | Why? |
| Gene Products, pol | 1 | 2010 | 13 | 0.03 | Why? |
| Biological Evolution | 1 | 2016 | 641 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2013 | 835 | 0.03 | Why? |
| Extremities | 1 | 2012 | 179 | 0.03 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.03 | Why? |
| Contact Tracing | 2 | 2020 | 8448 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Alleles | 1 | 2016 | 1557 | 0.03 | Why? |
| Gene Order | 1 | 2010 | 144 | 0.03 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Fluorescence | 1 | 2012 | 475 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Immunization Schedule | 1 | 2017 | 1305 | 0.02 | Why? |
| Blotting, Western | 1 | 2012 | 863 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2010 | 449 | 0.02 | Why? |
| Mutant Proteins | 1 | 2010 | 328 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Cytochromes b | 1 | 2007 | 23 | 0.02 | Why? |
| Nandiniidae | 1 | 2007 | 19 | 0.02 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
| Chimera | 1 | 2007 | 83 | 0.02 | Why? |
| Receptor, Angiotensin, Type 2 | 1 | 2010 | 190 | 0.02 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.02 | Why? |
| Orthoreovirus, Mammalian | 1 | 2007 | 10 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.02 | Why? |
| Molecular Epidemiology | 1 | 2013 | 1638 | 0.02 | Why? |
| Binding, Competitive | 1 | 2007 | 264 | 0.02 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Replicon | 1 | 2008 | 232 | 0.02 | Why? |
| Models, Genetic | 1 | 2009 | 434 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Biomedical Technology | 1 | 2010 | 257 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Hemagglutinins, Viral | 1 | 2006 | 176 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Mutagenesis | 1 | 2007 | 394 | 0.02 | Why? |
| Virion | 1 | 2013 | 1444 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Epitope Mapping | 1 | 2010 | 1240 | 0.02 | Why? |
| Guillain-Barre Syndrome | 1 | 2018 | 1495 | 0.02 | Why? |
| Antibody Affinity | 1 | 2010 | 1078 | 0.02 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.02 | Why? |
| Virus Assembly | 1 | 2007 | 438 | 0.02 | Why? |
| Models, Molecular | 2 | 2010 | 7616 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.02 | Why? |
| Amino Acid Substitution | 1 | 2010 | 1706 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Immune Evasion | 1 | 2011 | 2081 | 0.01 | Why? |
| HIV | 1 | 2007 | 1116 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.01 | Why? |
| Protein Conformation | 1 | 2010 | 4386 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Cells, Cultured | 1 | 2010 | 5835 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 11367 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2015 | 9044 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |